Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma

NCT06357117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2024-04-11

No results posted yet for this study

Summary

The extent of intrahepatic infiltration of perihilar cholangiocarcinoma (PHCC) remains unclear. This research aimed to explore the pattern and extent of intrahepatic infiltration of PHCC to guide surgical treatment and pathological research. This prospective study included 62 participants diagnosed with PHCC who underwent major hepatectomy. A whole-mount digital liver pathology system (WDLPS) for hepatectomy specimens greater than 10 × 10 cm was used to panoramically assess the intrahepatic infiltration extent of PHCC.

Conditions

  • Perihilar Cholangiocarcinoma

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Principal Investigators

  • Shuo Jin, PhD · Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University

Eligibility

Min Age
44 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-13
Primary Completion
2021-12-22
Completion
2021-12-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06357117 on ClinicalTrials.gov